Open | $0.920 |
Close | $0.923 |
Volume / Avg. | 2.005M / 1.426M |
Day Range | 0.895 - 0.968 |
52 Wk Range | 0.572 - 2.575 |
Market Cap | $157.689M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 54 |
Short Interest | % |
Days to Cover | 10.59 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of X4 Pharmaceuticals (NASDAQ: XFOR) through any online brokerage.
Other companies in X4 Pharmaceuticals’s space includes: Molecular Partners (NASDAQ:MOLN), Syros Pharmaceuticals (NASDAQ:SYRS), Zura Bio (NASDAQ:ZURA), CytomX Therapeutics (NASDAQ:CTMX) and Atossa Therapeutics (NASDAQ:ATOS).
The latest price target for X4 Pharmaceuticals (NASDAQ: XFOR) was reported by B. Riley Securities on Tuesday, December 12, 2023. The analyst firm set a price target for 1.00 expecting XFOR to rise to within 12 months (a possible 6.09% upside). 8 analyst firms have reported ratings in the last year.
The stock price for X4 Pharmaceuticals (NASDAQ: XFOR) is $0.9426 last updated March 18, 2024 at 7:21 PM EDT.
There are no upcoming dividends for X4 Pharmaceuticals.
X4 Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for X4 Pharmaceuticals.
X4 Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.